1. Home
  2. GMED vs NBIX Comparison

GMED vs NBIX Comparison

Compare GMED & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$87.84

Market Cap

12.9B

Sector

Health Care

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$132.70

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
NBIX
Founded
2003
1992
Country
United States
United States
Employees
N/A
2000
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
13.2B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
GMED
NBIX
Price
$87.84
$132.70
Analyst Decision
Buy
Strong Buy
Analyst Count
14
22
Target Price
$100.42
$175.27
AVG Volume (30 Days)
822.9K
810.0K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
422.67
41.95
EPS
3.92
4.67
Revenue
$2,938,931,000.00
$161,626,000.00
Revenue This Year
$11.13
$22.85
Revenue Next Year
$6.28
$10.36
P/E Ratio
$22.00
$28.20
Revenue Growth
16.65
977.51
52 Week Low
$51.79
$84.23
52 Week High
$101.40
$160.18

Technical Indicators

Market Signals
Indicator
GMED
NBIX
Relative Strength Index (RSI) 52.92 54.02
Support Level $85.61 $128.03
Resistance Level $92.48 $136.74
Average True Range (ATR) 2.14 3.27
MACD 0.15 0.47
Stochastic Oscillator 98.34 80.18

Price Performance

Historical Comparison
GMED
NBIX

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: